Results 111 to 120 of about 1,973 (151)

[Guardians of Immune Tolerance: Regulatory T Cells]. [PDF]

open access: yesSichuan Da Xue Xue Bao Yi Xue Ban
Ming K, Zhang H, Hu H.
europepmc   +1 more source

[Treatment of extramedullary recurrent multiple myeloma with daretozumab in combination with the DECP regimen: a case report]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2021
Wei ZL   +6 more
europepmc   +1 more source

[Prevalence characteristics of autoimmune thyroid disease in women aged 10-59 years in Qingdao City from 2022 to 2024]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Chen X   +8 more
europepmc   +1 more source

[Guidelines for the diagnosis and management of first relapsed multiple myeloma in China (2022)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2022
Plasma Cell Disease Group   +3 more
europepmc   +1 more source

[Precise measurement of human heart rate based on multi-channel radar data fusion]. [PDF]

open access: yesSheng Wu Yi Xue Gong Cheng Xue Za Zhi
Guo H, Cao H, Yang K, Zhang Z.
europepmc   +1 more source

[Immune-related severe pneumonia: A case report]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Liu J, Liu G, Zhu Y.
europepmc   +1 more source

[The treatment strategies of autoimmune hemolytic anemia]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Yue WR, Wu T, Wang XQ.
europepmc   +1 more source

[Guidelines for the diagnosis and management of first relapsed multiple myeloma in China (2026)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy